Export 2 results:
Filters: Author is Alméras, Natalie [Clear All Filters]
Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics. World J Biol Psychiatry. 2020:1-8.
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry. 2004;65(4):557-64.